in the literature. We herein report a case of JXG with cutaneous, cerebral, and spinal involvement in a young boy with spontaneous regression of the lesions.
Case Report

History and Examination
The JXG diagnosis was suspected when the patient was 19 months old as his scalp and gluteal region ( Fig. 1 ) had multiple yellow-red papulo-nodular skin lesions. Additionally, the boy presented with neurological symptoms including a delay in walking acquisition associated with distal paraparesis and urinary incontinence. Therefore, cerebral and spinal MRI was performed, which demonstrated the presence of 3 intracerebral nodular lesions located in the left temporal lobe (Fig. 2) as well as an intramedullary spinal cord lesion extending from T-8 to L-1 and associated with spinal cord malformation (high spinal cord; Fig. 3 ). The MRI showed the heterogeneous aspect of the intramedullary spinal cord lesion, isointense on T1-weighted sequences with a cystic component hyperintense on T2-weighted sequences. The initial diagnosis of cutaneous JXG was histologically confirmed by biopsy of a nodular skin lesion (Fig. 4) . The patient was then referred to our pediatric neurosurgical center, and we proposed to perform a biopsy of the unusual intramedullary spinal cord lesion.
Operation
To decrease the risk of postoperative spine deformity, the biopsy was performed via a posterior interlaminar approach at the low thoracic level (T10-11). Macroscopically, the spinal cord was enlarged and yellowish. Histologically, some large histiocytes were present in glial tissue-some of them with lipidized cytoplasm-along with some lymphocytes and eosinophils. These histiocytes expressed CD68, CD163, as well as factor XIIIa to a lesser extent (Fig. 5) . These features confirmed the diagnosis of intramedullary spinal cord JXG.
Postoperative Course
Given the histopathological results, the unresectability of the lesion, and the stability of the clinical signs over several months, we opted for close clinical and MRI follow-up. The boy started to walk at 33 months of age. We prescribed oxybutynin to limit the symptoms of urinary incontinence. Additionally, he underwent a motor rehabilitation program.
During follow-up, we observed gradual regression of the skin, cerebral, and intramedullary spinal cord lesions (Figs. 1-3) on MRI performed 6 months after surgery. After 9 years of follow-up, the patient is autonomous and can run and cycle. He wears night splints to correct his foot deformities, which have been stable for many years.
Discussion
Central and peripheral nervous system involvement by JXG is rare. Only 48 cases have been reported so far. Thirty-three cases involved the central nervous system, 12 cases involved the peripheral nervous system, and 3 cases involved intraosseous JXGs, whose primary origin was a vertebral body. 1, 8, 16, 19 Of the 12 patients with JXG lesions of the peripheral nervous system, 4 patients (33%) had lesions in the trigeminal nerve, 3 patients (25%) had lesions in a peripheral nerve, 3 patients (25%) had lesions in a spinal nerve, and 2 patients (17%) had lesions in the cauda equina. 1, 8 Of the 33 patients with a central nervous system lesion of JXG, 22 patients (67%) had lesions in the brain, the cerebellum, or the posterior fossa and 1 patient (3%) each had a lesion in the optic nerve, the sellar region, and the cavernous sinus. 1, 8, 19 Involvement of the spinal cord by JXG was reported in 8 patients, and all lesions had an extramedullary location. 8, 16 Thus, our report is the first to describe an intramedullary spinal cord lesion of JXG associated with both brain and cutaneous lesions that all regressed spontaneously.
Central and peripheral nervous system involvement by JXG have distinct clinical presentations. Central nervous system lesions of JXG predominantly affect males. These patients are also affected at a younger age, compared to patients with peripheral nervous system lesions (5.75 vs 20.5 years, respectively). 8 Additionally, central nervous system involvement by JXG is more frequently associated with cutaneous lesions than is peripheral nervous system involvement (46% vs 10%).
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Diagnosis of JXG can prove difficult, especially in cases of solitary extracutaneous lesions, as clinical and macroscopically intraoperative findings can be nonspecific. Concerning differential diagnoses of JXG lesions involving the spinal cord, nerve roots, and peripheral nerves, nerve sheath tumors and meningioma should be considered. 5, 6, 8, 11, 14, 15, 20, 22, 23 Therefore, histopathological examination is the gold standard for diagnosing JXG. 8 However, the pathologist must rule out differential diagnoses when encountering xanthomatous lesions of the nervous system in children, such as nonneoplastic lesions (infarcts, demyelination, or infection), xanthomas associated with hyperlipidemia, and glial neoplasms (pleomorphic xanthoastrocytoma, granular cell astrocytoma, and oligodendroglioma). Other types of histiocytic disorders-mostly Langerhans cell histiocytosis-should also be ruled out. of histiocytic dendrocytic differentiation (CD68, CD4, CD163, and factor XIIIa). 4, 8, 17 Juvenile xanthogranuloma is often revealed by a solitary cutaneous lesion, 7, 13 which usually resolves spontaneously within 3 years. 12 Systemic JXG is a rare disease and occurs in 4%-10% of patients with a solitary cutaneous lesion. 7, 10 It also frequently develops without skin lesions. 10 However, a solitary cutaneous lesion often predates systemic JXG lesions that involve the central nervous system. 8, 10 Therefore, when encountering cutaneous skin lesions of JXG, the clinician should be aware of possible associated extracutaneous lesions, including those of the central nervous system. He or she must also refer the patient for multidisciplinary care if some unusual symptoms occur. In the case of a cutaneous JXG lesion confirmed by the histopathological examination, the discovery of an intramedullary spinal cord lesion (with an MRI aspect similar to that in our case) should not necessarily lead to a biopsy. In fact, the indication for biopsy depends on the evolution of the clinical signs and the MRI aspects.
Management of nervous system lesions of JXG is highly heterogeneous in the literature and includes resection, chemotherapy, corticosteroids, or supportive care. 1, 8 Of the 33 patients reported with a JXG lesion of the central nervous system, 17 were treated only surgically, 6 had medical treatment (chemotherapy and/or corticotherapy), 2 had both surgical and medical treatments, 5 underwent chemotherapy and radiotherapy, 1 patient was observed, and treatment was unknown in 2 patients. 1, 8, 16, 19 Fifty-eight percent and 17% of the patients were disease free after surgery and after medical treatment (chemotherapy and/or corticotherapy), respectively. 1, 8, 16, 19 All the patients treated with chemotherapy and radiotherapy had an intracerebral lesion, and complete remission was never attained. 8 Botella-Estrada et al. described a patient with multiple cutaneous lesions and asymptomatic JXG lesions of the cerebrum and cerebellum that were untreated and remained stable during follow-up. 2 Recently, Miyake et al. have shown the possibility of spontaneous regression of a residual tumor of the occipital lobe after partial resection, which was indicated for epilepsy. 19 Curative treatments reported in the literature do not seem more effective than supportive care in JXG. This highlights the potential for stability or for spontaneous resolution of JXG lesions. Moreover, curative treatments, in particular chemotherapy and radiotherapy, can lead to severe adverse effects in young children and should be reserved for progressive and/or life-threatening JXG lesions. 10 Although the choice of treatment should be guided by clinical signs, patient complaints, general health status, lesion locations, and safe resectability, clinicians should keep in mind that JXG-including intramedullary spinal cord lesions-may resolve spontaneously, as shown in our report.
Conclusions
We provided the first description of an intramedullary spinal cord lesion of JXG associated with cutaneous and cerebral lesions. Similar to those in other locations, the lesion resolved spontaneously within 7 years, without any medical or surgical treatment. However, if no treatment is provided, we would recommend close clinical and MRI follow-up for these patients.
